Basic Study
Copyright ©The Author(s) 2021.
World J Gastrointest Oncol. Jul 15, 2021; 13(7): 693-705
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.693
Table 1 Correlation between expression of phosphorylated Src homology 2 domain–containing phosphatase 2 and other clinicopathologic characteristics
Factors
Expression of p-SHP2
χ2
P value
Positive, n (%)
Negative, n (%)
Age (yr)≤ 6011 (21.6)6 (11.8)0.3080.579
> 6020 (39.2)14 (27.5)
GenderMale24 (47.1)16 (31.4)0.0001.0001
Female7 (13.7)4 (7.8)
Tumor locationCardia18 (35.5)9 (17.6)0.8330.361
non-cardia13 (25.5)11 (21.6)
DifferentiationWell11 (29.41)12 (17.65)2.9510.086
Poor20 (17.65)8 (35.29)
Tumor size ≥ 5 cm18185.9720.015
< 5 cm132
T stageT1-T27 (13.7)15 (29.4)13.6180.000
T3-T424 (47.1)5 (9.8)
N stageN08 (15.7)15 (29.4)11.8820.001
N1-N323 (45.1)5 (9.8)
TNM stageⅠ, Ⅱ10 (19.6)16 (31.4)11.0880.001
Ⅲ, Ⅳ21 (41.2)4 (7.8)
CagA-IgGPositive 18 (35.3)4 (7.8)7.1810.007
Negative 13 (25.5)16 (31.4)